相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
37
- 英文名:
Mirodenafil dihydrochloride
- CAS号:
862189-96-6
- 供应商:
上海莼试
- 保存条件:
Store at -20°C
- 规格:
5mg 10mg 50mg 100mg 200mg 500mg
| 产品名称 | Mirodenafil dihydrochloride | 产品货号 | CS-01Y68792 |
| 规格 | 5mg 10mg 50mg 100mg 200mg 500mg | CAS号 | 862189-96-6 |
| 含量 | >98.00% | 分子式 | C26H39Cl2N5O5S |
| 分子量 | 604.59 | 用途 | 仅供科研研究使用 |

Mirodenafil dihydrochloride (SK3530 dihydrochloride) is a phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction.Target: PDE5Mirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor. Mirodenafil, in doses of 50 or 100 mg, significantly improved erectile function and were well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities [1]. The concurrent administration of mirodenafil with alcohol was not associated with clinically significant hemodynamic changes in these healthy male volunteers in Korea. The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil administered with alcohol had a tolerability profile comparable to that of mirodenafil alone [2]. In these healthy Korean male volunteers, the coadministration of ketoconazole and rifampicin resulted in significant changes in systemic exposure to mirodenafil [3
化学性质:

规格:5mg 10mg 50mg 100mg 200mg 500mg
CAS:862189-96-6
别名:N/A
化学名:N/A
分子式:C26H39Cl2N5O5S

分子量:604.59
溶解度:DMSO: ≥ 100 mg/mL (165.40 mM)
储存条件:Store at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition: Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
使用方法:

1. 常用筛选浓度
注意:用来筛选稳转株的工作浓度需要根据细胞类型,培养基,生长条件和细胞代谢率而变化,推荐使用浓度为50-1000μg/mL。对于第一次使用的实验体系建议通过建立杀灭曲线(kill curve),即剂量反应性曲线,来确定最佳筛选浓度。
一般而言,哺乳动物细胞50-500μg/mL;细菌/植物细胞20-200μg/mL;真菌300-1000μg/mL。
2. 杀灭曲线的建立
注意:为了筛选得到稳定表达目的蛋白的细胞株,需要确定能够杀死未转染宿主细胞的抗生素浓度,可通过建立杀灭曲线(剂量反应曲线)来实现,至少选择5个浓度。
1) 第一天:未转化的细胞按照20-25%的细胞密度铺在合适的培养板上,37℃,CO2培养过夜;注:对于需要更高密度来检测活力的细胞,可增加接种量。
2) 根据细胞类型,设定合适范围内的浓度梯度。以哺乳动物细胞为例,可设定50,100,250,500,750,1000μg/mL。先用去离子水或者PBS buffer按照1:10的比例将母液稀释到5 mg/ml,然后按照下表稀释到相应浓度的工作液。
3) 第二天:替换旧的培养基,换用新鲜配制的含有相应浓度药物的培养基。每个浓度做三个平行孔。
4) 接下来每3-4天更换新的含药物培养基。
5) 按照固定的周期(如每2天)进行活细胞计数来确定阻止未转染细胞生长的恰当浓度。选择在理想的天数(通常是7-10天)内能够杀死绝大多数细胞的浓度为稳定转染细胞筛选用的工作浓度。
3. 稳定转染细胞的筛选
1) 转染48h后,用含有适当浓度的潮霉素B筛选培养基来传代细胞(直接传代或者稀释后传代)。
注意:细胞处于活跃分裂状态时抗生素的杀伤。则当细胞过于稠密,其效率会降低。为了得到较好的筛选效果,最好将细胞稀释至丰度不超过25%
2) 每隔3-4天更换含有药物的筛选培养液。
3) 筛选7天后观察并评估细胞克隆(集落)的形成情况。集落的形成可能还需要一周或者更多的时间,这取决于宿主细胞类型,转染,以及筛选效果。
4) 挑取并转移5-10个抗性克隆于35mm细胞培养板,继续用含药物的筛选培养液维持培养7天。
5) 之后更换正常培养基培养即可。
蛋白酶抑制剂混合物实验步骤:

(1)Mirodenafil dihydrochloride实验开始前将RNA提取液于65℃水浴锅中预热,离心管中加入ME(巯基乙醇),(10mL加80ul,50mL中加入300ul)
(2)取约0.8g菌丝体(液体培养获得的菌丝用真空抽滤即可!固体培养就更好说了),在液氮中迅速磨成精细粉末,装入50mL离心管,按1g材料8mL的量加入预热的RNA提取液,颠倒混匀
(3)65℃水浴3-10 min,期间混匀2-3次
(4)加入等体积的酚(注意是酸酚pH4.5)::yi戊醇(25:24:1)抽提(10,000rpm,4℃,5 min)
(5)取上清,等体积的yi戊醇(24:1)抽提(10,000rpm,4℃,5 min)
(6)加入1/4V体积10M LiCl溶液,4℃放置6h以上(或过夜)
(7)10,000rpm,4℃离心20min
(8)弃上清,用500ul SSTE溶解沉淀
(9)酚::yi戊醇(25:24:1)抽提两次,:yi戊醇(24:1)抽提1次(10,000rpm,4℃,5min)
(10)加2V体积的无水乙醇,在-70℃冰箱沉淀30min以上
(11)12,000rpm,4℃离心20 min
(12)弃上清.沉淀用70%酒精漂洗一次,干燥
(13)加200ul的DEPC处理水溶解
(14)用非变性琼脂糖凝胶电泳和紫外分光光度计扫描检测RNA的质量(在抽提过程中,若蛋白质含量或其它的杂质还较多,可以增加抽提次数)
公司正在出售的产品:

| Recombnant Human MAGEA11, N-H | DGKB Antibody Blocking Peptide |
| Recombinant Human Carbonic Anhydrase 14 | Recombinant Phosphodiesterase 4D, cAMP Specific (PDE4D) |
| Folate Receptor 4 Antibody Blocking Peptide | Recombinant Phosphodiesterase 9A (PDE9A) |
| Ube2G2/UBC7 Antibody Blocking Peptide | Recombinant Phosphodiesterase 12 (PDE12) |
| CYP2U1 Antibody Blocking Peptide | Recombinant Phosphodiesterase 10A (PDE10A) |
| CHRNB4 Antibody Blocking Peptide | Recombinant 2',5'-Oligoadenylate Synthetase 2 (OAS2) |
| ARRB2 Antibody Blocking Peptide | Recombinant 2',5'-Oligoadenylate Synthetase 3 (OAS3) |
| NHLH1 + NHLH2 Antibody Blocking Peptide | 神经突触相关蛋白LTRK5封闭多肽 |
| MetAP1 Antibody Blocking Peptide | Recombinant Lysyl Oxidase Like Protein 4 (LOXL4) |
| CBY1 Antibody Blocking Peptide | Recombinant Lysyl Oxidase Like Protein 2 (LOXL2) |
| DNAJC2 Antibody Blocking Peptide | Recombinant Lysyl Oxidase Like Protein 1 (LOXL1) |
| NFATC3 Antibody Blocking Peptide | Recombinant Janus Kinase 2 (JAK2) |
| RAB20 Antibody Blocking Peptide | Mirodenafil dihydrochlorideRecombinant Janus Kinase 3 (JAK3) |
| CFAP45 Antibody Blocking Peptide | Recombinant Hyaluronan Synthase 2 (HAS2) |
| GNPDA2 Antibody Blocking Peptide | Recombinant Stearoyl Coenzyme A Desaturase (SCD) |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验疟原虫 Malaria Parasites(Plasmodium)
can be used:Quinine dihydrochloride 20 mg salt/kg base given I.V. in 5% w/v dextrose or normal saline as a once-only 4 hour infusion followed, 4 hours later, by quinine dihydrochloride 10 mg salt/kg base 4-hour infusions 8 hourly.Where a syringe pump
Measuring Antioxidant Capacity Using the ORAC and TOSC Assays
by antioxidants, and the second is the total oxyradical scavenging capacity (TOSC) assay, which measures the decrease in ethylene gas production caused by the inhibition of the thermal hydrolysis of ABAP (2,2′-Azobis(2-methyl-(propionamidine) dihydrochloride
for each d12 mm coverslip, 25 µl for square coverslip and 50µl for full size coverslip• Seal the coverslip with nail polish• Store in 4 C up to 2 weeksDAPI stock• 4’, 6-Diamidino-2-phenylindole dihydrochloride hydrate (DAPI) from Sigma (Cat# D-9542), 1 mg 1mg
技术资料暂无技术资料 索取技术资料








